<p>Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis

Published:2020-02 Issue: Volume:Volume 12 Page:1493-1502
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Shen Yuxiu,Han Zaigang,Liu Shuang,Jiao Yang,Li Ying,Yuan Hongyan

Publisher

Informa UK Limited

Subject

Oncology

Reference42 articles.

1. Cancer treatment and survivorship statistics, 2014

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. Breast cancer statistics, 2017, racial disparity in mortality by state

4. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure

5. Chemotherapy-Resistant Metastatic Breast Cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EFFECT of CURCUMIN on BREAST CANCER CELLS THROUGH miR-145-5p AND ITS TARGET GENES;Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi;2024-06-04

2. Anticancer Properties of Curcuma longa;Advances in Medical Diagnosis, Treatment, and Care;2024-04-19

3. Curcumin inhibits colorectal cancer development by blocking the YAP/TAZ signaling axis;BIOCELL;2024

4. Curcumin with nanocarriers as cancer therapeutics: An update;THE FOURTH SCIENTIFIC CONFERENCE FOR ELECTRICAL ENGINEERING TECHNIQUES RESEARCH (EETR2022);2023

5. Discovery of anticancer therapeutics: Computational chemistry and Artificial Intelligence-assisted approach;Computational Methods in Drug Discovery and Repurposing for Cancer Therapy;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3